Core Insights - Southbound funds reduced their holdings in Baize Medical (02609.HK) by 1.5576 million shares on February 11, indicating a trend of net selling over the past five trading days, with a total net reduction of 775,800 shares [1] - Over the last 20 trading days, there were 11 days of net buying by southbound funds, accumulating to a total net increase of 6.9 million shares [1] - As of now, southbound funds hold 72.9198 million shares of Baize Medical, representing 5.52% of the company's total issued ordinary shares [1] Company Overview - Baize Medical Group is primarily engaged in investment and provision of medical-related services, focusing on oncology [1] - The company offers comprehensive oncology medical services, including screening, diagnosis, treatment, and rehabilitation [1] - Its business operations encompass hospital services, hospital management, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - The company also provides cancer diagnosis, treatment, rehabilitation, and end-of-life care, along with early cancer screening, cancer vaccination, and health management services for other potential healthy populations [1] - Baize Medical primarily operates in the Chinese market [1]
佰泽医疗（02609.HK）：2月11日南向资金减持155.76万股